Investigation of mechanisms involved in (-)-borneol-induced vasorelaxant response on rat thoracic aorta

Basic Clin Pharmacol Toxicol. 2012 Feb;110(2):171-7. doi: 10.1111/j.1742-7843.2011.00784.x. Epub 2011 Sep 28.

Abstract

The monoterpene (-)-borneol is present in essential oils of several medicinal plants. The aim of this study was to evaluate (-)-borneol effects on rat thoracic aorta artery rings. The cumulative addition of (-)-borneol (10(-9) -3 × 10(-4) M) on a phenylephrine-induced pre-contraction (10(-6) M) promoted a vasorelaxant effect in a concentration-dependent manner and independent of vascular endothelium. A similar effect was obtained on KCl-induced pre-contractions (80 mM). (-)-Borneol (10(-5) -3 × 10(-4 ) M) inhibited contractions induced by cumulative addition of CaCl2 (10(-6) -3 × 10(-2) M) in depolarizing medium without Ca(2+) in a concentration-dependent manner. On S-(-) Bay K 8644-induced pre-contractions (10(-7) M), (-)-borneol did not induce significant changes compared with KCl-induced pre-contractions. In a Ca(2+) -free medium, (-)-borneol (10(-5) , 10(-4) or 10(-3) M) interfered in calcium mobilization from phenylephrine (10(-6) M)- or caffeine (20 mM)-sensitive intracellular stores. The involvement of K(+) channels was evaluated by tetraethylammonium (3 mM), 4-aminopyridine (1 mM) and glibenclamide (10(-5) M) pre-treatment, and (-)-borneol-induced vasorelaxation was markedly attenuated. Thus, this vasorelaxant effect can probably be attributed to calcium influx blockade through voltage-operated calcium channels (CaV L), calcium mobilization from intracellular stores and potassium channels activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / adverse effects
  • 4-Aminopyridine / pharmacology
  • Animals
  • Aorta, Thoracic / drug effects*
  • Calcium Chloride / adverse effects
  • Camphanes / pharmacology*
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Glyburide / pharmacology
  • Phenylephrine / adverse effects
  • Potassium Channels / drug effects
  • Potassium Chloride / adverse effects
  • Rats
  • Tetraethylammonium / pharmacology
  • Vasodilator Agents / pharmacology*

Substances

  • Camphanes
  • Potassium Channels
  • Vasodilator Agents
  • Phenylephrine
  • Tetraethylammonium
  • Potassium Chloride
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • 4-Aminopyridine
  • isoborneol
  • Calcium Chloride
  • Glyburide